- Home
- GLMD vs ADIL Comparison
GLMD vs ADIL Comparison
Compare GLMD & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- ADIL
- Stock Information
- Founded
- GLMD 2000
- ADIL 2010
- Country
- GLMD Israel
- ADIL United States
- Employees
- GLMD N/A
- ADIL N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- GLMD Health Care
- ADIL Health Care
- Exchange
- GLMD Nasdaq
- ADIL Nasdaq
- Market Cap
- GLMD 6.6M
- ADIL 7.7M
- IPO Year
- GLMD 2014
- ADIL 2018
- Fundamental
- Price
- GLMD $1.18
- ADIL $0.32
- Analyst Decision
- GLMD Hold
- ADIL Strong Buy
- Analyst Count
- GLMD 1
- ADIL 2
- Target Price
- GLMD N/A
- ADIL $4.75
- AVG Volume (30 Days)
- GLMD 65.7K
- ADIL 440.9K
- Earning Date
- GLMD 11-14-2025
- ADIL 11-13-2025
- Dividend Yield
- GLMD N/A
- ADIL N/A
- EPS Growth
- GLMD N/A
- ADIL N/A
- EPS
- GLMD N/A
- ADIL N/A
- Revenue
- GLMD N/A
- ADIL N/A
- Revenue This Year
- GLMD N/A
- ADIL N/A
- Revenue Next Year
- GLMD N/A
- ADIL N/A
- P/E Ratio
- GLMD N/A
- ADIL N/A
- Revenue Growth
- GLMD N/A
- ADIL N/A
- 52 Week Low
- GLMD $1.15
- ADIL $0.22
- 52 Week High
- GLMD $3.61
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- GLMD 32.65
- ADIL 49.53
- Support Level
- GLMD $1.16
- ADIL $0.31
- Resistance Level
- GLMD $1.27
- ADIL $0.38
- Average True Range (ATR)
- GLMD 0.08
- ADIL 0.02
- MACD
- GLMD -0.02
- ADIL -0.00
- Stochastic Oscillator
- GLMD 0.00
- ADIL 54.41
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.